BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20176859)

  • 1. The silent side of the spectrum: schizotypy and the schizotaxic self.
    Raballo A; Parnas J
    Schizophr Bull; 2011 Sep; 37(5):1017-26. PubMed ID: 20176859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Looking at the schizophrenia spectrum through the prism of self-disorders: an empirical study.
    Raballo A; Sæbye D; Parnas J
    Schizophr Bull; 2011 Mar; 37(2):344-51. PubMed ID: 19528205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention.
    Tsuang MT; Stone WS; Tarbox SI; Faraone SV
    Schizophr Res; 2002 Mar; 54(1-2):169-75. PubMed ID: 11853991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders.
    Kendler KS; McGuire M; Gruenberg AM; Walsh D
    Arch Gen Psychiatry; 1995 Apr; 52(4):296-303. PubMed ID: 7702446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of familial schizophrenia using a psychometric measure of schizotypy.
    Lenzenweger MF; Loranger AW
    Arch Gen Psychiatry; 1989 Oct; 46(10):902-7. PubMed ID: 2802929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia.
    Stone WS; Hsi X; Tan L; Zhu S; Li L; Giuliano AJ; Seidman LJ; Tsuang MT
    Asian J Psychiatr; 2012 Mar; 5(1):83-92. PubMed ID: 22773937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of self-report and clinician-rated schizotypal traits in schizotypal personality disorder and community controls.
    Chan CC; Bulbena-Cabre A; Rutter S; Benavides C; McClure MM; Calabrese W; Rosell DR; Koenigsberg HW; Goodman M; New AS; Hazlett EA; Mercedes Perez-Rodriguez M
    Schizophr Res; 2019 Jul; 209():263-268. PubMed ID: 30635257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent validation of schizotaxia: a pilot study.
    Stone WS; Faraone SV; Seidman LJ; Green AI; Wojcik JD; Tsuang MT
    Biol Psychiatry; 2001 Sep; 50(6):434-40. PubMed ID: 11566160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Schizotaxia": clinical implications and new directions for research.
    Faraone SV; Green AI; Seidman LJ; Tsuang MT
    Schizophr Bull; 2001; 27(1):1-18. PubMed ID: 11215539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimensionality vs taxonicity of schizotypy: some new data and challenges ahead.
    Everett KV; Linscott RJ
    Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S465-74. PubMed ID: 25810059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizotaxia, schizotypy, and schizophrenia: Paul E. Meehl's blueprint for the experimental psychopathology and genetics of schizophrenia.
    Lenzenweger MF
    J Abnorm Psychol; 2006 May; 115(2):195-200. PubMed ID: 16737381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?
    Diwadkar VA; Montrose DM; Dworakowski D; Sweeney JA; Keshavan MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):230-8. PubMed ID: 16318899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives.
    Fanous A; Gardner C; Walsh D; Kendler KS
    Arch Gen Psychiatry; 2001 Jul; 58(7):669-73. PubMed ID: 11448374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-disorders and the schizophrenia spectrum: a study of 100 first hospital admissions.
    Nordgaard J; Parnas J
    Schizophr Bull; 2014 Nov; 40(6):1300-7. PubMed ID: 24476579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial aggregation of schizotypy in schizophrenia-spectrum disorders and its relation to clinical and neurodevelopmental characteristics.
    Soler J; Ferentinos P; Prats C; Miret S; Giralt M; Peralta V; Fañanás L; Fatjó-Vilas M
    J Psychiatr Res; 2017 Jan; 84():214-220. PubMed ID: 27764693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis proneness and clinical psychopathology: examination of the correlates of schizotypy.
    Lenzenweger MF; Loranger AW
    J Abnorm Psychol; 1989 Feb; 98(1):3-8. PubMed ID: 2708636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric high-risk paradigm, perceptual aberrations, and schizotypy: an update.
    Lenzenweger MF
    Schizophr Bull; 1994; 20(1):121-35. PubMed ID: 8197410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizotypal disorder: at the crossroads of genetics and nosology.
    Battaglia M; Torgersen S
    Acta Psychiatr Scand; 1996 Nov; 94(5):303-10. PubMed ID: 9124076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of schizotypy among multigenerational multiplex schizophrenia families.
    Tarbox SI; Almasy L; Gur RE; Nimgaonkar VL; Pogue-Geile MF
    J Abnorm Psychol; 2012 May; 121(2):396-406. PubMed ID: 22288909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizotypal personality disorder in individuals with and without schizophrenic relatives: similarities and contrasts in neurocognitive and clinical functioning.
    Condray R; Steinhauer SR
    Schizophr Res; 1992 Apr; 7(1):33-41. PubMed ID: 1591195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.